File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Patterns of relapse in 169 patients treated with oral arsenic trioxide during induction and/or maintenance

TitlePatterns of relapse in 169 patients treated with oral arsenic trioxide during induction and/or maintenance
Authors
KeywordsMedical sciences
Hematology
Issue Date2013
PublisherFondazione Ferrata Storti. The Journal's web site is located at http://www.haematologica.org/
Citation
The 18th Congress of the European Hematology Association (EHA 2013), Stockholm, Sweden, 13-16 June 2013. In Haematologica, 2013, v. 98 suppl. 1, p. 23, abstract P056 How to Cite?
AbstractBACKGROUND: Despite excellent response rates and long-term survivals with current treatment strategies, multiple relapses and central nervous system (CNS) disease remain major causes of treatment failure and mortality in patients with acute promyelocytic leukaemia (APL). AIMS: In this study, 169 patients with APL treated with oral arsenic trioxide (As2O3) during maintenance at first complete remission (CR1), or as re-induction and subsequent maintenance, were prospectively investigated. We aimed at describing different patterns of relapse, identifying risk factors for relapse and CNS disease, and prognostic factors for survival ...
DescriptionPoster Session 1 - Acute myeloid leukemia - Clinical 1: P056
This journal suppl. entitled: Abstract Book: 18th Congress of the European Hematology Association ... 2013
Open Access Journal
Persistent Identifierhttp://hdl.handle.net/10722/207345
ISSN
2015 Impact Factor: 6.671
2015 SCImago Journal Rankings: 3.010
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorGill, Hen_US
dc.contributor.authorLeung, AYHen_US
dc.contributor.authorTse, EWCen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2014-12-19T10:54:30Z-
dc.date.available2014-12-19T10:54:30Z-
dc.date.issued2013en_US
dc.identifier.citationThe 18th Congress of the European Hematology Association (EHA 2013), Stockholm, Sweden, 13-16 June 2013. In Haematologica, 2013, v. 98 suppl. 1, p. 23, abstract P056en_US
dc.identifier.issn0390-6078-
dc.identifier.urihttp://hdl.handle.net/10722/207345-
dc.descriptionPoster Session 1 - Acute myeloid leukemia - Clinical 1: P056-
dc.descriptionThis journal suppl. entitled: Abstract Book: 18th Congress of the European Hematology Association ... 2013-
dc.descriptionOpen Access Journal-
dc.description.abstractBACKGROUND: Despite excellent response rates and long-term survivals with current treatment strategies, multiple relapses and central nervous system (CNS) disease remain major causes of treatment failure and mortality in patients with acute promyelocytic leukaemia (APL). AIMS: In this study, 169 patients with APL treated with oral arsenic trioxide (As2O3) during maintenance at first complete remission (CR1), or as re-induction and subsequent maintenance, were prospectively investigated. We aimed at describing different patterns of relapse, identifying risk factors for relapse and CNS disease, and prognostic factors for survival ...-
dc.languageengen_US
dc.publisherFondazione Ferrata Storti. The Journal's web site is located at http://www.haematologica.org/en_US
dc.relation.ispartofHaematologicaen_US
dc.subjectMedical sciences-
dc.subjectHematology-
dc.titlePatterns of relapse in 169 patients treated with oral arsenic trioxide during induction and/or maintenanceen_US
dc.typeConference_Paperen_US
dc.identifier.emailLeung, AYH: ayhleung@hku.hken_US
dc.identifier.emailTse, EWC: ewctse@hku.hken_US
dc.identifier.emailKwong, YL: ylkwong@hku.hken_US
dc.identifier.authorityLeung, AYH=rp00265en_US
dc.identifier.authorityTse, EWC=rp00471en_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.pmcidPMC3684198-
dc.identifier.hkuros241800en_US
dc.identifier.volume98en_US
dc.identifier.issuesuppl. 1en_US
dc.identifier.spage23, abstract P056en_US
dc.identifier.epage23, abstract P056en_US
dc.publisher.placeItaly-
dc.customcontrol.immutablesml 141230-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats